Logo
S

Savara Pharmaceuticals

42 employees

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection in cystic fibrosis.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
respiratory
lung
MRSA
Biopharma
therapeutics
drug delivery
inhaler
biopharma
pulmonary
cystic fibrosis
dry-powder
infectious disease
dpi
biotech
aerosol

Date founded

2007

Funding rounds raised

Total raised

$20M

from 7 investors over 7 rounds

S

Savara Pharmaceuticals raised $20M on March 1, 2016

Investors: Carthona Capital, Keiretsu Capital, Keiretsu Forum Northwest, Green Park & Golf Ventures and Haas Portman Family Office

S

Savara Pharmaceuticals raised undisclosed on July 30, 2014

Investors: Green Park & Golf Ventures

S

Savara Pharmaceuticals raised undisclosed on March 1, 2013

Investors: Moore Venture Partners

FAQ